Saquinavir

Saquinavir is a first-generation HIV protease inhibitor and active pharmaceutical ingredient used as part of combination antiretroviral therapy (ART) for HIV-1 infection. Mediocon Inc supplies high-purity Saquinavir API conforming to BP / EP / USP specifications from our GMP-certified facility in Aurangabad, Maharashtra, India.

Saquinavir inhibits the HIV-1 protease enzyme, preventing viral polyprotein processing and thus the maturation of infectious HIV particles. It is used in combination with ritonavir (as a pharmacokinetic booster) in antiretroviral regimens.

Key Features

• High-purity pharmaceutical grade API
• BP / EP / USP compliant
• Full CoA and MSDS documentation
• GMP certified manufacturing

Applications

• HIV-1 antiretroviral combination therapy
• HIV protease inhibitor formulations
• Boosted protease inhibitor regimens
• Antiviral pharmaceutical research

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings